Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shanghai Becomes J&J's First Innovation Site Outside North America

Executive Summary

By the second quarter of 2019, the doors to a new Johnson & Johnson innovation facility will open in Shanghai, China – the ninth unit to launch under the US giant's JLABS initiative but only the first site outside of North America.

You may also be interested in...



J&J Hones In On Research Alliances, Human Capital As It Expands Singapore Hub

J&J is building its broad presence in Asia Pacific with the opening of an expanded regional hub in Singapore that will pursue R&D partnership, "design-led" health solutions, and human resource development.

Accessing Venture Debt From The EIB

Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.

In Vivo's 2024 Rising Leaders At A Glance

Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC099998

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel